Anti-SARS-CoV-2 Antibody Levels Predict Outcome in COVID-19 Patients with Type 2 Diabetes: A Prospective Cohort Study

Investigators conducted a prospective multicenter cohort study on 1152 patients with COVID-19 from five hospitals. Anti-SARS-CoV-2-spike-antibodies, creatinine, and NTproBNP were measured on hospital admission.